After artemisinin, another life-saving drug that innovates from the source is born in China
In their 11th year of establishment, they submitted their first answer sheet - a new Chinese original drug from start to finish. Unlike generic drugs and follow-up innovative drugs with clear pathways, this complete innovation from discovering the mechanism of viral infection, target action to drug development is rare in the history of Chinese pharmaceuticals. Wang Xiaodong, the director of Beisheng Institute, once wrote that when he returned to China to work full-time more than ten years ago, there were only two original innovative drugs recognized by the world that China could produce: artemisinin for treating malaria and arsenic for treating acute promyelocytic leukemia.